1-10 of 10
Sunil K. Joshi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Trial Testing the Novel Combination Therapy of Entrectinib and ASTX727 in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia Patients

Cristina Tognon, Shikha Mishra, Andy Kaempf, Byung Park, Sunil K Joshi, Ariane Huang, Stephen E. Kurtz, Luca Sax, Christopher A. Eide, Kara Johnson, Rachel Mahoney, Michael James Lue, Nicole Tong, Lisa Guiducci, Tara Lundberg Willians, Emma Indira Solanki, Rachel J. Cook, Jessica T. Leonard, Curtis A Lachowiez, Gabrielle Meyers, Jennifer N. Saultz, Elie Traer, Jeffrey W. Tyner, Uma Borate, Ronan T. Swords
Journal: Blood
Blood (2024) 144 (Supplement 1): 1498.
https://doi.org/10.1182/blood-2024-208505
Published: 2024
Journal Articles

Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+Venetoclax

Jennifer N. Saultz, Manoj Rai, Faith Burns, Daniel J Chandra, Sunil K Joshi, Curtis A. Lachowiez, Andy Kaempf, Andrew N Nemecek, Yoko Kosaka, Evan F. Lind, Stephen E. Kurtz, Nicola Long, Rachel Cook, Gabrielle Meyers, Arpita Gandhi, Jessica T. Leonard, Brandon Hayes-Lattin, Laura F. Newell, Richard T Maziarz, Elie Traer, Ronan T. Swords, Theodore P Braun, Cristina Tognon, Jeffrey W Tyner
Journal: Blood
Blood (2023) 142 (Supplement 1): 5762.
https://doi.org/10.1182/blood-2023-188311
Published: 2023
Journal Articles

Defining Clinical and Molecular Biomarkers for Venetoclax-Based Drug Combinations to Augment AML Therapy

Christopher A. Eide, Stephen E. Kurtz, Andy Kaempf, Nicola Long, Sunil K Joshi, Tamilla Nechiporuk, Ariane Huang, Charles Dibb, Daniel Bottomly, Shannon K. McWeeney, Bill H. Chang, Brian J. Druker, Jeffrey W. Tyner
Journal: Blood
Blood (2022) 140 (Supplement 1): 1025–1027.
https://doi.org/10.1182/blood-2022-159264
Published: 2022
Journal Articles

The FLT3 F691L Gatekeeper Mutation Promotes Clinical Resistance to Gilteritinib + Venetoclax (GILT + VEN) in AML

Setareh Sharzehi, Sunil K Joshi, Janét Pittsenbarger, Jeffrey W. Tyner, Elie Traer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2235.
https://doi.org/10.1182/blood-2021-145762
Published: 2021
Journal Articles

Evolution of Gilteritinib Resistance from Residual Disease to Relapse

Sunil K Joshi, BA, Tamilla Nechiporuk, PhD, Daniel Bottomly, Paul Piehowski, Paul.Piehowski@pnnl.gov, Julie Reisz, PhD, Janét Pittsenbarger, BA, Sara J Gosline, Andy Kaempf, MS, Yi-Ting Wang, Jamie Moon, Özgün Babur, Kevin M Watanabe-Smith, PhD, Emek Demir, Liu Tao, BS, PhD, Cristina E. Tognon, PhD, Angelo D'Alessandro, PhD, Jeffrey W. Tyner, PhD, Shannon K. McWeeney, PhD, Karin Rodland, rodland@ohsu.edu, Brian J. Druker, MD, Elie Traer
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-139084
Published: 2020
Journal Articles

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms

Sunil K. Joshi, Kristin Qian, William H. Bisson, Kevin Watanabe-Smith, Ariane Huang, Daniel Bottomly, Elie Traer, Jeffrey W. Tyner, Shannon K. McWeeney, Monika A. Davare, Brian J. Druker, Cristina E. Tognon
Journal: Blood
Blood (2020) 135 (24): 2159–2170.
https://doi.org/10.1182/blood.2019003691
Published: 2020
Includes: Supplemental data
Journal Articles

Discovery & Characterization of Therapeutically Targetable Ntrk Point Mutations in Leukemia

Sunil K Joshi, BA, William Bisson, PhD, Kristin Qian, Ariane Huang, Kevin Watanabe-Smith, PhD, Jeffrey W. Tyner, Monika Ashok Davare, PhD, Shannon K. McWeeney, PhD, Cristina E. Tognon, Brian J. Druker
Journal: Blood
Blood (2019) 134 (Supplement_1): 1256.
https://doi.org/10.1182/blood-2019-125908
Published: 2019
Journal Articles

Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease

Robert H. Broyles, PhD, Professor/ASH Member, Sunil K. Joshi, PhD BS, DVM, MS, Carol D. Curtis, PhD, Austin C. Roth, B.A., Patrick A. Floyd, Marie Trudel, DSc, Visar Belegu, PhD, Ashley A. Baker, MD, Robert A.. Floyd, PhD
Journal: Blood
Blood (2014) 124 (21): 1357.
https://doi.org/10.1182/blood.V124.21.1357.1357
Published: 2014
Journal Articles

Ferritin-H and a Phytotherapeutic, Alone or Combined, Reprogram RBC Precursor Cells From SCD Patients to Produce Levels of Fetal Hemoglobin That Constitute a Phenotypic Cure for Sickle Cell As Well As Providing Resistance to Malaria and a Probable Treatment for Beta-Thalassemia

Robert H. Broyles, PhD, Visar Belegu, Ph.D., Austin C. Roth, B.A., Emily J. Curry, B.S., Robert A. Floyd, Ph.D., Sonia Levi, Ph.D., Paolo Arosio, Ph.D., Paolo Santambrogio, Ph.D., Marie Trudel, DSc, Sunil K. Joshi, Ph.D., D.V.M/
Journal: Blood
Blood (2011) 118 (21): 903.
https://doi.org/10.1182/blood.V118.21.903.903
Published: 2011
Journal Articles

Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2

J. Pablo Abonia, K. Frank Austen, Barrett J. Rollins, Sunil K. Joshi, Richard A. Flavell, William A. Kuziel, Pandelakis A. Koni, Michael F. Gurish
Journal: Blood
Blood (2005) 105 (11): 4308–4313.
https://doi.org/10.1182/blood-2004-09-3578
Published: 2005